1-244858744-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_031844.3(HNRNPU):​c.1215G>A​(p.Val405Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00233 in 1,571,030 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 7 hom. )

Consequence

HNRNPU
NM_031844.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.70

Publications

2 publications found
Variant links:
Genes affected
HNRNPU (HGNC:5048): (heterogeneous nuclear ribonucleoprotein U) This gene encodes a member of a family of proteins that bind nucleic acids and function in the formation of ribonucleoprotein complexes in the nucleus with heterogeneous nuclear RNA (hnRNA). The encoded protein has affinity for both RNA and DNA, and binds scaffold-attached region (SAR) DNA. Mutations in this gene have been associated with epileptic encephalopathy, early infantile, 54. A pseudogene of this gene has been identified on chromosome 14. [provided by RefSeq, Jun 2017]
HNRNPU Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 54
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-244858744-C-T is Benign according to our data. Variant chr1-244858744-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 414103.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00163 (249/152322) while in subpopulation NFE AF = 0.0022 (150/68028). AF 95% confidence interval is 0.00192. There are 0 homozygotes in GnomAd4. There are 110 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 249 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_031844.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HNRNPU
NM_031844.3
MANE Select
c.1215G>Ap.Val405Val
synonymous
Exon 6 of 14NP_114032.2
HNRNPU
NM_004501.3
c.1158G>Ap.Val386Val
synonymous
Exon 6 of 14NP_004492.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HNRNPU
ENST00000640218.2
TSL:1 MANE Select
c.1215G>Ap.Val405Val
synonymous
Exon 6 of 14ENSP00000491215.1
HNRNPU
ENST00000444376.7
TSL:1
c.1158G>Ap.Val386Val
synonymous
Exon 6 of 14ENSP00000393151.2
HNRNPU
ENST00000639628.2
TSL:1
c.387G>Ap.Val129Val
synonymous
Exon 3 of 11ENSP00000491340.1

Frequencies

GnomAD3 genomes
AF:
0.00164
AC:
249
AN:
152204
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.0121
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00220
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00203
AC:
508
AN:
249906
AF XY:
0.00212
show subpopulations
Gnomad AFR exome
AF:
0.000309
Gnomad AMR exome
AF:
0.00187
Gnomad ASJ exome
AF:
0.0114
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000925
Gnomad NFE exome
AF:
0.00254
Gnomad OTH exome
AF:
0.00262
GnomAD4 exome
AF:
0.00240
AC:
3411
AN:
1418708
Hom.:
7
Cov.:
25
AF XY:
0.00239
AC XY:
1691
AN XY:
708310
show subpopulations
African (AFR)
AF:
0.000399
AC:
13
AN:
32610
American (AMR)
AF:
0.00189
AC:
84
AN:
44422
Ashkenazi Jewish (ASJ)
AF:
0.0117
AC:
301
AN:
25810
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39392
South Asian (SAS)
AF:
0.000483
AC:
41
AN:
84906
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53374
Middle Eastern (MID)
AF:
0.00564
AC:
32
AN:
5674
European-Non Finnish (NFE)
AF:
0.00257
AC:
2760
AN:
1073568
Other (OTH)
AF:
0.00290
AC:
171
AN:
58952
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
136
272
409
545
681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00163
AC:
249
AN:
152322
Hom.:
0
Cov.:
32
AF XY:
0.00148
AC XY:
110
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41572
American (AMR)
AF:
0.00216
AC:
33
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
42
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00220
AC:
150
AN:
68028
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00250
Hom.:
1
Bravo
AF:
0.00170
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00344
EpiControl
AF:
0.00457

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HNRNPU: BS1, BS2

Nov 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 05, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Developmental and epileptic encephalopathy, 54 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Mar 16, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
17
DANN
Benign
0.76
PhyloP100
2.7
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.8
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.43
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.43
Position offset: 3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147232928; hg19: chr1-245022046; COSMIC: COSV99310122; COSMIC: COSV99310122; API